GGrantIndex
← Leaderboards

Diana J Wilkie

University Of Washington

Google Scholar ↗PubMed ↗ORCID ↗
$16,363,356
Attributed
$30,519,608
Total exposure
15
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $6M · FY2005–25
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$59,407,340 · 19

By mechanism

U54$27,199,641 · 5
R01$23,161,727 · 10
UH3$6,352,490 · 1
P30$2,685,982 · 2
R13$7,500 · 1

Top collaborators

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Top investigators on “Innovation”

Research focus

InnovationAmericanEvaluationResearch PersonnelAfricanEffectivenessMalignant NeoplasmsCommunitiesDesignCaringUniversitiesFloridaFosteringSuccessBenchmarkingMortalityUnited StatesPilot ProjectsResearch Project GrantsComprehensive Cancer CenterInstitutionPublicationsEducation ResearchMethodology

Grant awards (92)

3/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Center$1,148,169
U54 · FY2025 · CA
2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Center$1,054,791
U54 · FY2025 · CA · contact PI
1/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Center$1,023,664
U54 · FY2025 · CA
Administrative Core - 2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Center$117,200
U54 · FY2025 · CA · contact PI
2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Center$68,558
U54 · FY2025 · CA · contact PI
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain$1,584,065
UH3 · FY2024 · AT
2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$1,002,053
U54 · FY2024 · CA · contact PI
1/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$972,480
U54 · FY2024 · CA
3/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$820,069
U54 · FY2024 · CA
CHOICES for Sickle Cell Reproductive Health: RCT of a Preconception Intervention Model for a Single Gene Disorder$747,237
R01 · FY2024 · HG · contact PI
1/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$236,349
U54 · FY2024 · CA
Administrative Core - 2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$204,302
U54 · FY2024 · CA · contact PI
2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$65,130
U54 · FY2024 · CA · contact PI
Administrative Core - 2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$36,263
U54 · FY2024 · CA · contact PI
CaRE2 NCI Diversity Supplement$21,580
U54 · FY2024 · CA · contact PI
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain$1,582,439
UH3 · FY2023 · AT
3/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$1,145,283
U54 · FY2023 · CA
2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$1,054,791
U54 · FY2023 · CA · contact PI
1/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$993,062
U54 · FY2023 · CA
CHOICES for Sickle Cell Reproductive Health: RCT of a Preconception Intervention Model for a Single Gene Disorder$762,479
R01 · FY2023 · HG · contact PI
Building Data Science Capacity to Enhance Research and Diversity at a Historically Black University$249,977
U54 · FY2023 · CA
Administrative Core - 2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$216,507
U54 · FY2023 · CA · contact PI
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain$1,573,843
UH3 · FY2022 · AT
3/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$1,118,428
U54 · FY2022 · CA
2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$1,033,700
U54 · FY2022 · CA · contact PI
1/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$994,198
U54 · FY2022 · CA
CHOICES for Sickle Cell Reproductive Health: RCT of a Preconception Intervention Model for a Single Gene Disorder$762,491
R01 · FY2022 · HG · contact PI
African Bi-Costal (ABC) Cancer Study$124,539
U54 · FY2022 · CA
Admin-Core-001$124,539
U54 · FY2022 · CA
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain$1,612,143
UH3 · FY2021 · AT
3/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$1,141,251
U54 · FY2021 · CA
2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$1,054,792
U54 · FY2021 · CA · contact PI
1/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$891,935
U54 · FY2021 · CA
CHOICES for Sickle Cell Reproductive Health: RCT of a Preconception Intervention Model for a Single Gene Disorder$762,494
R01 · FY2021 · HG · contact PI
2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$1,221,701
U54 · FY2020 · CA · contact PI
3/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$1,141,254
U54 · FY2020 · CA
1/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$835,986
U54 · FY2020 · CA
Dignity Therapy RCT led by Nurses or Chaplains for Elderly Cancer Outpatients$637,130
R01 · FY2020 · CA · contact PI
Defining the molecular genomic landscae and tumor microenvironment of squamous non-small cell lung cancer in a raciall diverse cohort$165,479
U54 · FY2020 · CA
3/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$1,107,013
U54 · FY2019 · CA
2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$1,023,148
U54 · FY2019 · CA
1/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$977,974
U54 · FY2019 · CA
Dignity Therapy RCT led by Nurses or Chaplains for Elderly Cancer Outpatients$618,015
R01 · FY2019 · CA · contact PI
The Role of the Mito-Transcriptome in the Pathogenesis of Alzheimer's Disease and its relation to Prostate Cancer and Androgen Blockade$412,490
U54 · FY2019 · CA
2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$196,159
U54 · FY2019 · CA
Evaluating the Tablet-based Turkish-PAINReportIt for Assessing Pain of Lung Cancer Patients Post Thoracotomy in TURKEY$138,310
R01 · FY2019 · CA · contact PI
3/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$1,141,251
U54 · FY2018 · CA
2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$1,054,795
U54 · FY2018 · CA
1/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$1,008,781
U54 · FY2018 · CA
Dignity Therapy RCT led by Nurses or Chaplains for Elderly Cancer Outpatients$637,130
R01 · FY2018 · CA · contact PI
HL-Phenotypic Characterization of Chronic Pain in Adults with Sickle Cell Disease$823,373
R01 · FY2017 · HL
Dignity Therapy RCT led by Nurses or Chaplains for Elderly Cancer Outpatients$640,513
R01 · FY2017 · CA · contact PI
Evaluating the Tablet-based Turkish-PAINReportIt for Assessing Pain of Lung Cancer Patients Post Thoracotomy in TURKEY$142,588
R01 · FY2017 · CA · contact PI
HL-Phenotypic Characterization of Chronic Pain in Adults with Sickle Cell Disease$827,237
R01 · FY2016 · HL
Dignity Therapy RCT led by Nurses or Chaplains for Elderly Cancer Outpatients$712,498
R01 · FY2016 · CA · contact PI
HL-Phenotypic Characterization of Chronic Pain in Adults with Sickle Cell Disease$779,804
R01 · FY2015 · HL
HL-Phenotypic Characterization of Chronic Pain in Adults with Sickle Cell Disease$30,780
R01 · FY2015 · HL · contact PI
HL-Phenotypic Characterization of Chronic Pain in Adults with Sickle Cell Disease$778,692
R01 · FY2014 · HL · contact PI
Describing, Contrasting, and Visualizing End-of-Life Care in the 21st Century$497,206
R01 · FY2014 · NR
Sickle Cell Reproductive CHOICES: Efficacy of a Primary Prevention Intervention$485,312
R01 · FY2014 · HL
Sickle Cell Reproductive CHOICES: Efficacy of a Primary Prevention Intervention$585,671
R01 · FY2013 · HL · contact PI
Describing, Contrasting, and Visualizing End-of-Life Care in the 21st Century$476,193
R01 · FY2013 · NR
Sickle Cell Reproductive CHOICES: Efficacy of a Primary Prevention Intervention$609,098
R01 · FY2012 · HL · contact PI
Describing, Contrasting, and Visualizing End-of-Life Care in the 21st Century$502,396
R01 · FY2012 · NR
Describing, Contrasting, and Visualizing End-of-Life Care in the 21st Century$501,021
R01 · FY2011 · NR
Center for End-of-Life Transition Research (CEoLTR)$456,033
P30 · FY2011 · NR · contact PI
Pain in Sickle Cell Disease: Basic & Clinical Science Advances and Future Directi$7,500
R13 · FY2011 · HL
Center for End-of-Life Transition Research (CEoLTR)$407,122
P30 · FY2010 · NR · contact PI
Computerized PAINRelievelt for Adult Sickle Cell Disease$852,782
R01 · FY2009 · HL · contact PI
Effects & Costs of Massage in Hospice Cancer Patients$461,274
R01 · FY2009 · NR · contact PI
Center for End-of-Life Transition Research (CEoLTR)$399,753
P30 · FY2009 · NR · contact PI
Center for End-of-Life Transition Research (CEoLTR)$175,914
P30 · FY2009 · NR · contact PI
Computerized PAINRelievelt for Adult Sickle Cell Disease$684,082
R01 · FY2008 · HL · contact PI
Center for End-of-Life Transition Research (CEoLTR)$468,080
P30 · FY2008 · NR · contact PI
Computerized PAINRelievelt for Adult Sickle Cell Disease$153,400
R01 · FY2008 · HL · contact PI
Computerized PAINRelievelt for Adult Sickle Cell Disease$686,484
R01 · FY2007 · HL · contact PI
Center for End-of-Life Transition Research (CEoLTR)$480,000
P30 · FY2007 · NR · contact PI
Effects & Costs of Massage in Hospice Cancer Patients$432,178
R01 · FY2007 · NR · contact PI
Admin Core$299,080
P30 · FY2007 · NR · contact PI
Computerized PAINRelievelt for Adult Sickle Cell Disease$747,374
R01 · FY2006 · HL · contact PI
Computerized PAINRelieveIt Protocol for Cancer Pain$609,232
R01 · FY2006 · CA · contact PI
Effects & Costs of Massage in Hospice Cancer Patients$435,670
R01 · FY2006 · NR · contact PI
Computerized PAINRelieveIt Protocol for Cancer Pain$605,084
R01 · FY2005 · CA
Effects &Costs of Massage in Hospice Cancer Patients$512,638
R01 · FY2005 · NR
Computerized PAINRelieveIt Protocol for Cancer Pain$592,776
R01 · FY2004 · CA
Computerized PAINRelieveIt Protocol for Cancer Pain$583,014
R01 · FY2003 · CA
COMPUTERIZED SYMPTOM REPORT CONSULT FOR CANCER PATIENTS$450,344
R01 · FY2002 · CA
COMPUTERIZED SYMPTOM REPORT CONSULT FOR CANCER PATIENTS$489,632
R01 · FY2001 · CA
COMPUTERIZED PAIN REPORT &NURSING PAIN CONSULT PROTOCO$444,287
R01 · FY2001 · CA
COMPUTERIZED SYMPTOM REPORT CONSULT FOR CANCER PATIENTS$43,154
R01 · FY2001 · CA
COMPUTERIZED SYMPTOM REPORT CONSULT FOR CANCER PATIENTS$489,495
R01 · FY2000 · CA
COMPUTERIZED PAIN REPORT &NURSING PAIN CONSULT PROTOCO$431,159
R01 · FY2000 · CA